Anteris Technologies' Wayne Paterson provides an overview of a proposal that's landed on the company's desk, which asks it to consider a merger with NASDAQ-listed special purpose acquisition company Medicus Sciences Acquisition Corp. It's still early days for the proposal, but if a transaction goes through, the merged entity would have at least US$50 million in cash, plus the existing funds held by the company. Moving ahead, AVR plans to do the math and weigh up the proposal's risks and rewards as it considers bringing the offer to shareholders for further consideration.